21 May 2009
Impact of tumour characteristic on the outcome of liver transplantation in patients with HCC
K Dudek, O Kornasiewicz, P Remiszewski, K Kobryń, B Ziarkiewicz-Wróblewska, B Górnicka, K Zieniewicz, M KrawczykAnn Transplant 2009; 14(1): 28-28 :: ID: 880299
Abstract
Background: The aim of this study was to identify predictors of survival of 58
patients, with hepatocellular carcinoma (HCC) in cirrhotic liver, treated by liver transplantation (OLTx).
Material/Methods: From January 2001 to December 2008 655 OLTx were
performed in 615 patients. HCC was diagnosed in 58 patients before OLTx and in 66 at histological examination of the explanted livers. 72% of the patients had met Milan criteria at histology.
Results: The median follow-up was 27 months (range, 1-96). We analyzed patient's age and gender, aetiology of liver disease, Child's score at transplantation, episodes of rejection, number and tumour's size, presence of vascular invasion and tumour's differentiation grade. There was no statistically significant difference in survival among patients grouped according to the MELD staging system for HCC. Outcome of the 5-year survival of patients with low differentiated (G3) HCC was significantly worse than patients with moderately differentiated (G2) or well-differentiated (G1) HCC (respectively, G3 50%, G2 81%, and G1 86%, p<0.01). Patients with micro-vascular invasion had a worse 5-yr survival than patients without vascular invasion (42%vs. 80%, p<0.01).
Conclusions: The analysis indicates that histological grade of the tumour and
microscopic vascular invasion are the most predictive factors of overall survival in patients with cirrhosis after liver transplantation for HCC.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






